Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Receive your first dose Your plan may include GLP-1s, oral medication, or a combination of both
Scientific References Vitamin B12 or folate deficiency anaemia Treatment
Mounjaro (tirzepatide) is a prescription medication licensed by the MHRA for the treatment of type 2 diabetes mellitus and for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Required documentation elements: Drug name, dose, route of administration (SC or IM), and anatomical injection site Medical necessity statement linking the injection to an active diagnosis (with corresponding ICD-10 code) Date and time of administration Provider signature and credentials Patients response or tolerance to the injection, where clinically relevant NDC number and lot number for drug traceability (required by many payers and Medicare for some J-codes) Common denial reasons and how to avoid them Four denial triggers account for the majority of rejected 96372 claims
It may aid in fat metabolism, helping the body process fats and carbohydrates more efficiently
For long-term health benefits, like improved mood, better cognitive function, and enhanced overall well-being, a consistent and regular schedule of B12 injections is often necessary
